| Literature DB >> 35204241 |
Adriany das Graças Nascimento Amorim1, Andreanne Gomes Vasconcelos2,3,4, Jessica Souza5, Ana Oliveira6, Beatriz Gullón7, José Roberto de Souza de Almeida Leite2, Manuela Pintado6.
Abstract
The purpose of this review was to collect relevant chemical data about lycopene and its isomers, which can be extracted using different non-polar or polar aprotic solvents by SC-CO2 or biosynthesis as a friendly technique. Lycopene and other carotenoids can be identified and quantified by UV-Vis and HPLC using a C18 or C30 column, while their characterization is possible by UV-Vis, Fluorescence, FTIR, MS, NMR, and DSC assays. Among these techniques, the last four can compare lycopene isomers and identify cis or all-trans-lycopene. FTIR, MS, and NMR techniques are more suitable for the verification of the purity of lycopene extracts due to the signal complexity generated for each isomer, which enables identification by subtle differences. Additionally, some biological activities of lycopene isolated from red vegetables have already been confirmed, such as anti-inflammatory, antioxidant, and cytotoxic activity against cancer cells, probably by activating several pathways. The encapsulation of lycopene in nanoparticles demonstrated an improvement in oral delivery, and ex vivo assessments determined that these nanoparticles had better permeation and low cytotoxicity against human cells with enhanced permeation. These data suggest that lycopene has the potential to be applied in the food and pharmaceutical industries, as well as in cosmetic products.Entities:
Keywords: anti-inflammatory; bio-availability; cancer; lycopene; nanostructure
Year: 2022 PMID: 35204241 PMCID: PMC8868408 DOI: 10.3390/antiox11020360
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Figure 1Representation of bio-availability and functions of lycopene in humans as well as products from foods, pharmaceutical and cosmetic products.
Figure 2Representation of cis and trans-lycopene structure. Data deposited in computer by PubChem [14] and converted to 2D with ACD/Labs [15].
Type of lycopene obtained from different extraction methods and biosynthesis from 2017 to 2021.
| Technique | Solvent/Mobile Phase/Flow Rate | Device | Temperature/ | Lycopene Source/ | References |
|---|---|---|---|---|---|
| Extraction | Hexane | Soxhlet extractor | 37 °C/6 h | Tomato peel and seed/ | [ |
| * SC-CO2/1 mL·min−1 | SFT 110 extractor | 40 and 80 °C/30 and 50 MPa/30, 45, 60, 90, 120, 180, 240 min | |||
| Hexane/Acetone/Ethanol (2:1:1) | Vortex | 2 h | |||
| Washed in 0.1 M NaCl | Tomato peel and seed/ | [ | |||
| OH pre-treatment | 55 °C/1 min | ||||
| Water/Ethanol (70%) | Thermal extraction | 55 °C/15 min | |||
| Water/Ethanol (1:6 | |||||
| OH application | Ohmic heating (OH) technology | 0–100 °C/30 min/ | |||
| * SC-CO2/1 L·min−1 | SFT 110 extractor | 60 °C and 40 MPa/ | Tomato peel and seed/ | [ | |
| Hexane | Soxhlet extractor/0.22 µm hydrophobic PTFE | 12 h | Tomato peel and seed/ | [ | |
| Olive oil | Maceration (15 to 150 min)/Magnetic stirrer/Box–Behnken | 40–80 °C/ | |||
| Methanol/Ethyl acetate/ | Tomato peel and seed from 10 varieties/ | [ | |||
| 30% Methanolic potassium hydroxide | Room temperature | ||||
| Saturated saline solution/ | Washed | ||||
| Dry over anhydrous | Rotary evaporator | 35 °C | |||
| PEF (pre-treatment)1,3; 5 kV·cm−1/0.012 kJ·kg−1, 0.160 kJ·kg−1, 0.475 kJ·kg−1/10 Hz/20 μs | 20 ± 2 °C | Tomato peels/ | [ | ||
| Acetone (1:40 | Extraction flask | 25 °C/0–24 h | |||
| Ethyl lactate (1:40 | |||||
| Ethyl acetate | Thermal extraction | 75 °C/1 or 2 h | Plum tomato peels/ | [ | |
| Ultrasounds | Approximately 0 °C/30 min | ||||
| Magnesium carbonate (20%) (sample/solution 1:1) | Orbital shaker | 25 °C/2 h | Tomato peels/ | [ | |
| Ultrasonic | 50 °C/30 min (10 times) | ||||
| Centrifuge | 10 °C/10 min | ||||
| Reduced volume | 40 °C/Low pressure | ||||
|
|
|
|
|
|
|
| Biosynthesis | Isopropyl- | Shaking flask |
| Lycopene | [ |
| Glucose | Shake flask |
| Lycopene | [ | |
| Glucose + Glycerol | Shake flask | Lycopene | [ | ||
| Glucose | |||||
| Oleic acid | Bioreactor | ||||
| Glucose | |||||
| Glucose + oleic acid + yeast extract | |||||
| Glucose + waste cooking oil + yeast extract | |||||
| Lactic acid | Flask fermentation | Lycopene and | [ |
* SC-CO2 = Supercritical Carbon Dioxide; (w/v) & = sample weight/solvent volume.
Characterization and quantification methods for cis and trans-lycopene from 2017 to 2021.
|
|
|
|
|
|
| High-performance liquid | Acetonitrile/Methanol/ | C30 RPAQUEOUS | [ | |
| [ | ||||
| [ | ||||
| Methanol/ | C30 YMC | [ | ||
| A: Ethyl acetate | C18 Vydac 201TP54 C (250 × 4.6 mmm) + C18 pre-column | Total carotenoids in | [ | |
| Methanol/Methyl butyl ether/Ethyl acetate (50:40:10) | C30 YMC | [ | ||
| Acetonitrile/ | C18 Eclipse XDB (3.5 μm; 4.6 mm × 250 mm) | Lycopene | [ | |
| A: Methanol/Water (98:2) | C30 YMC (3 μm, 250 × 4.6 mm) + C30 guard column (20 × 4.6 mm) | [ | ||
| A: Acetonitrile/water | C18 Nucleodur 300-5 | Lycopene, | [ | |
| Methanol (27%)/ | C30 YMC | [ | ||
| Acetonitrile/Methanol (10:90, | C18 reverse-phase ODS2 | [ | ||
| A: Acetone/water | C18 Zorbax | Lycopene | [ | |
| Acetonitrile/Methanol/ | RPAQUEOUS Develosil-C30 | Lycopene isomer | [ | |
|
|
|
|
|
|
| UV–Vis | Chloroform:Ethanol (1:20) | UV–Vis spectrophotometer | [ | |
| Chloroform:Ethanol | UV-1800 spectrophotometer | Lycopene | [ | |
| Water | Lycopene | |||
| Spectrophotometer | Lycopene | [ | ||
| Acetone | Spectrophotometer | Lycopene | [ | |
| Acetone | V-650 UV–Vis spectrophotometer | Lycopene | [ | |
| Ethyl acetate | Lycopene | |||
| Ethanol | UV–Vis spectrophotometer | Lycopene | [ | |
|
|
|
|
|
|
| Fourier Transform Infrared (FTIR) | KBr | FTIR | Lycopene | [ |
| KBr | IRAffinity-1 spectrometer | [ | ||
| KBr | FTIR-ATR | Lycopene | [ | |
| Diamond crystal plate | FTIR-ATR | [ | ||
| KBr | FTIR spectrometer | [ | ||
|
|
|
|
|
|
| Mass | 5–18 eV/180 °C/ | MS/MS Mass spectrometer | [ | |
| 15 eV/180 µL·h−1 | Mass spectrometer | [ | ||
| HRMS ESI [M]+ | Lycopene | [ | ||
|
|
|
|
|
|
| CDCl3 | Discovery Studio 3.5 + B3LYP + 6-311G (d, p) | [ | ||
| 400 MHz 1H NMR/0–10 ppm | ||||
| 400 MHz 13C NMR/0–150 ppm | ||||
| D2O/25 ± 0.5 °C | Self-diffusion 1H NMR Avance III 600 MHz | Lycopene | [ | |
| CDCl3 | 1H NMR | [ | ||
|
|
|
|
|
|
| X-ray | 0.154 nm/40 kV/40 mA | D8 XRD diffractometer/ | Lycopene | [ |
| 50 kV/100 mA | X-ray diffractometer/ | [ | ||
| 1.54 Å/45 kV/40 mA | D8 XRD diffractometer/ | [ | ||
| 50 kV/100 mA | X-ray diffractometer/ | [ |
(GIAO)z = Gauge Invariance Atomic Orbital; TMSa = Tetramethylsilane.
Antimicrobial activity of lycopene or lycopene extracts from 2015 to 2021.
| Extract/Structure | Microorganisms | Results | References |
|---|---|---|---|
| Lycopene (5 µg/mL) |
| Antifungal effects against | [ |
| Carotenoids within | The nanoparticles were effective in preventing | [ | |
| Lycopene oleoresin | Oleoresin can inhibit and prevent the growth of relevant foodborne bacteria. | [ | |
| Lycopene extracts | Extract of lycopene presents | [ | |
| The microbial quality of the food samples was not highly affected (< 0.8 log units) during the storage period after the incorporation of lycopene microspheres. | [ | ||
| Lycopene extract | Gram (+): | Extracts of all cultivars were more effective against | [ |
Recent examples of methods used to encapsulate lycopene from 2017 to 2021.
| Delivery System | Encapsulation Method | Results | References |
|---|---|---|---|
| A mixture of methylene chloride solution of lycopene with ethanol at 37 °C. | Higher stability against oxidizing agents (AAPH and H2O2). | [ | |
| Lycopene inclusion complexes with | Increased thermal stability, photostability, and antioxidant activity. | [ | |
| Nanoliposomes | Sonication of lycopene, soybean phosphatidylcholine, cholesterol, and | Neuronal protection against cerebral ischemia/reperfusion. | [ |
| Phospholipid nanoliposomes | Nanospheres of phospholipids with lycopene produced by evaporation and nanoliposomes produced by sonication with the presence of buffer and | Enhanced antioxidant activity. | [ |
| Double-loaded | Lycopene, | Prolonged-release. | [ |
| Oil-in-water | Octenyl succinate anhydride-modified starch mixed with lycopene using high-pressure homogenization and medium-chain triglycerides as carrier oils. | Stable nano-emulsions system with potential application for | [ |
| Oil-in-water | Emulsion of water, pure whey isolate, citric acid, triglycerides, and lycopene created with pressure homogenizer. | Increased lycopene bio-accessibility. | [ |
| Nanodispersions | Homogenization of lycopene dissolved in dichloromethane, aqueous phase, | Small-size lycopene nanodispersions. | [ |
| Feed emulsions | Homogenization of tomato powders, maltodextrin, and gum Arabic in aqueous solution and encapsulation made | Increased lycopene stability. | [ |
| Solid lipid | Lycopene-loaded solid lipid nanoparticles using Precirol® ATO 5, Compritol® 888 ATO, and myristic acid by | Stable after 2 months in | [ |
| Solid lipid | Cold homogenization technique with glyceryl monostearate and lycopene. | Gel with a promising antioxidant therapy in periodontal defects. | [ |
| Solid lipid | Homogenization-evaporation technique of lycopene-loaded SLN with different ratios of biocompatible Compritol® 888 ATO | Particles showed in vitro | [ |
| Nanostructure lipid carriers (NLCs) | Ultrasonication of lycopene with | Enhanced oral bio-availability. | [ |
| Nanostructure lipid carriers (NLCs) | Homogenization and ultrasonication method (aqueous phase with Tween 80, lecithin, and lycopene). | Increased lycopene aqueous solubility. | [ |
| Nanostructure lipid carriers (NLCs) | Emulsion created with lycopene, a lipid mixture, Tween 80 followed by pressure homogenization. | Biphasic release pattern with fast release initially and a slower afterward. | [ |
| Whey protein isolate nanoparticles | Lycopene loaded whey protein | Enhance the oral bio-availability of lycopene. | [ |
| Gelatin nanofibers | A mixture of gelatin from bovine skin and tomato extract is used in electrospinning. | Better retention of lycopene. | [ |
| Ionic gelation | Lycopene watermelon concentrate mixed with sodium alginate or pectin. | More stable lycopene-rich beads. | [ |
| Nano-encapsulation | CPCs (Chlorella pyrenoidosa cells) | Feasibility of lycopene encapsulation in the CPCs. | [ |
| Nano-emulsion | Lycopene from guava on nanoemulsifying system of natural oils. | Lycopene nano-emulsion with | [ |
| Lipid-core Nanocapsules | Nano-encapsulation process mixed lycopene extract from guava with polycaprolactone polymer in acetone sorbitan monostearate. | The nanostructure was cytotoxic against cancer cells (human breast adenocarcinoma line MCF-7). | [ |
| Nanoparticle | Polymer nanoparticle fucan-coated based on acetylated cashew gum and lycopene extract from guava. | Promising results for applicability in hydrophobic compounds carrying systems as lycopene with cytotoxic effect on the breast cancer cell. | [ |
| Microencapsulation | Microencapsulation of lycopene from | The fine orange-yellow powder could be micro-encapsulated as stable | [ |
Number of patents after search on INPI, EPO, USPTO, and WIPO databases (in columns) using the keywords inserted in Table 5 lines.
| Keywords | INPI | INPI | USPTO | EPO | WIPO |
|---|---|---|---|---|---|
| Lycopene | 11 | 58 | 5532 | 29,979 | 30,220 |
| Guava | 1 | 45 | 3315 | 14,051 | 18,396 |
| Tomato | 34 | 187 | 38,236 | 150,308 | 171,583 |
|
| 0 | 14 | 978 | 2007 | 4568 |
| Lycopene and tomato | 5 | 7 | 1290 | 8113 | 8390 |
| Lycopene and tomato and extract | 0 | 1 | 881 | 5265 | 7313 |
| Lycopene and guava | 0 | 2 | 235 | 1496 | 1467 |
| Lycopene and guava and extract | 0 | 0 | 207 | 1317 | 1355 |
| Lycopene and nano | 0 | 0 | 543 | 2638 | 2689 |
| Lycopene and nano-emulsion | 0 | 0 | 111 | 482 | 930 |
| Lycopene and nano-emulsion and tomato | 0 | 0 | 23 | 105 | 173 |
| Lycopene and nano-emulsion and guava | 0 | 0 | 21 | 31 | 81 |
| Antimicrobial and Lycopene | 0 | 0 | 1440 | 4018 | 7289 |
| Antimicrobial and Lycopene and extract | 0 | 0 | 1069 | 3054 | 6785 |
| Antimicrobial and Lycopene and rich and extract | 0 | 0 | 491 | 1192 | 2615 |
| Antimicrobial and Lycopene and rich and extract and tomato | 0 | 0 | 126 | 402 | 1026 |
| Antimicrobial and Lycopene and rich and extract and guava | 0 | 0 | 51 | 105 | 181 |
| Total | 51 | 314 | 54,549 | 224,563 | 265,061 |
Source: Patents databases INPI, EPO, USPTO, and WIPO on 7 January 2022. For INPI database searching, the following terms in Portuguese were also used: Licopeno; Goiaba; Tomate; Psidium guajava; Licopeno e tomate; Licopeno e tomate e extrato; Licopeno e goiaba; Licopeno e tomate e extrato; Licopeno e goiaba e extrato; Licopeno e nano; Licopeno e nanoemulsão; Licopeno e nanoemulsão e tomate; Licopeno e nanoemulsão e goiaba; Antimicrobiano e Licopeno; Antimicrobiano e Licopeno e extrato; Antimicrobiano e Licopeno e rico e extrato; Antimicrobiano e Licopeno e rico e extrato e tomate; Antimicrobiano e Licopeno e rico e extrato e goiaba.